Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Centivax

Centivax

Stage unknownUS
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
1
Disclosed raised
$37.0Msum of rounds with a disclosed amount only
Named investors
6
Financing history
1 rounds
  1. Mar 30, 2026
    Funding round · $37.0M (disclosed)
    Structure Fund (lead)Meiji Seika Pharma Co (participant)BOLD Capital Partners (participant)Amplify Partners (participant)Base4 Capital LP (participant)Kendall Capital Partners (participant)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “Centivax Closes $37 Million Financing to Accelerate Phase 2 Clinical Development of Universal Flu and Advance Follow-On Portfolio to Clinical Readiness”
Investors on record
6 edges
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
  1. Mar 30, 2026
    Centivax announced Funding round of $37,000,000, led by Structure Fund
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
1 observations
Every observation on this company